You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
研報掘金丨中金:康龍化成主營業務持續向好,維持A/H股“跑贏行業”評級
中金公司研報指出,康龍化成預告1H25收入同比+13-16%,業績預告符合我們預期,公司收入保持良好增長態勢,盈利能力同比環比均有改善,主營業務持續向好。協同效應持續發揮,期待CDMO後期商業化能力得到兌現。公司堅持技術驅動,打造藥物研發前沿一站式平臺。2025年7月9日,公司與浙江大學簽訂全面戰略合作協議,共建“人工智能生命科學聯合研發中心”。維持2025年和2026年盈利預測不變。當前A股股價對應2025/2026年21.6倍/19.8倍市盈率,H股股價對應2025/2026年14.5倍/13.1 倍市盈率。A/H股維持“跑贏行業”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.